awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28069867-0373FE89-1DF6-4EDF-BB14-EB25049CB081
Q28069867-0373FE89-1DF6-4EDF-BB14-EB25049CB081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069867-0373FE89-1DF6-4EDF-BB14-EB25049CB081
A perspective on anti-EGFR therapies targeting triple-negative breast cancer
P2860
Q28069867-0373FE89-1DF6-4EDF-BB14-EB25049CB081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069867-0373FE89-1DF6-4EDF-BB14-EB25049CB081
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21879969ac494573fda97e9a2df604b26f5998c9
P2860
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.